Latest Disclosure Policy News

Worley Limited has affirmed its FY25 earnings were consistent with prior guidance and analyst expectations, with only a minor margin outperformance deemed immaterial. The company confirms compliance with ASX continuous disclosure rules following an ASX inquiry.

Terra Metals Limited has responded to an ASX price query following a sharp rise in its share price, confirming no undisclosed information is driving the movement and highlighting the start of Phase 3 drilling at its Dante Project.

Great Northern Minerals Limited has addressed an ASX query regarding the delayed filing of director interest notices, attributing the lapse to an administrative oversight related to option expiry. The company reassures investors that compliance frameworks remain robust.

Dotz Nano has responded to an ASX price query following unusual trading activity, confirming no undisclosed information and reaffirming compliance with continuous disclosure rules.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.

AGL Energy has clarified that its FY25 underlying earnings aligned with market forecasts and published guidance, dismissing any material surprises in its financial results. The company also addressed statutory profit volatility and confirmed compliance with ASX disclosure rules.

Weebit Nano has responded to an ASX price query following a sharp rise in its share price and trading volume, attributing the activity to a misleading article on the Motley Fool website. The company denies any undisclosed price-sensitive information and confirms full compliance with ASX disclosure rules.

Bayan Mining and Minerals Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed material information. The company attributes the price and volume surge to market speculation and news from nearby projects in the rare earth elements sector.

Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

Sequoia Financial Group has responded to an ASX price query, denying any undisclosed material information behind recent trading fluctuations and reaffirming compliance with listing rules amid ongoing ASIC investigations.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.